9VT-D Mini 4D TEE Probe
At a glance
Two years of proven outcomes
Small solution. Big impact. Advances in miniaturization have enabled the development of the mini 4D TEE (9VT-D), ensuring no compromise on image quality, while potentially improving workflow and setting a new industry standard.
Reduce size, not quality
A compact probe offering uncompromising image clarity
Helps minimize complications
Helps increase patient comfort while decreasing patient complications
Simplify LAA procedures
Smaller probe helps reduce the need for general anesthesia
Disclaimers
* 9VT-D is exclusively available on Vivid E95 and Vivid E90 with the Ultra Edition release since August 2022.
References
- Dr. Laura Sanchis is a paid consultant for GE HealthCare and was compensated for participation in the Vivid Magazine article. The statements by Dr. Laura Sanchis described here are based on her own opinions and on results that were achieved in her unique setting. Since there is no “typical” hospital/clinical setting and many variables exist, i.e. hospital size, case mix, staff expertise, etc. there can be no guarantee that others will achieve the same results.
- Dr. Marta Sitges is a paid consultant for GE HealthCare and was compensated for participation in the Vivid Magazine article. The statements by Dr. Marta Sitges described here are based on her own opinions and on results that were achieved in her unique setting. Since there is no “typical” hospital/clinical setting and many variables exist, i.e. hospital size, case mix, staff expertise, etc. there can be no guarantee that others will achieve the same results.
- The statements by Dr. Srikanth Vallurupalli described here are based on his own opinions and on results that were achieved in his unique setting. Since there is no “typical” hospital/clinical setting and many variables exist, i.e., hospital size, case mix, staff expertise, etc. there can be no guarantee that others will achieve the same results.
- Dr. Javier Gomez Valencia is a paid consultant for GE HealthCare and was compensated for participation in the Vivid Magazine article. The statements by Dr. Javier Gomez Valencia described here are based on his own opinions and on results that were achieved in his unique setting. Since there is no “typical” hospital/clinical setting and many variables exist, i.e. hospital size, case mix, staff expertise, etc. there can be no guarantee that others will achieve the same results.
- Dr. Jyothy Puthumana is a paid consultant for GE HealthCare and was compensated for participation in the Vivid Magazine article. The statements by Dr. Jyothy Puthumana described here are based on his own opinions and on results that were achieved in his unique setting. Since there is no “typical” hospital/clinical setting and many variables exist, i.e. hospital size, case mix, staff expertise, etc. there can be no guarantee that others will achieve the same results.
- First experience of left atrial appendage occlusion using a 3D mini transoesophageal echocardiographic probe with conscious sedation. Dr Laura Sanchis et al. EuroIntervention. 2023 Apr 24;18(17):1460-1461. doi: 10.4244/EIJ-D-22-00921 https://eurointervention.pcronline.com/article/first-experience-of-left-atrial-appendage-occlusion-using-a-3d-mini-transoesophageal-echocardiographic-probe-with-conscious-sedation.
- Initial Experience with the 4D Mini-TEE Probe in the Adult Population. Konstantinos Papadopoulos et al. J Clin Med 2024 Oct 28;13(21):6450. doi: 10.3390/jcm13216450. https://www.mdpi.com/2077-0383/13/21/6450